Cheelcare Inc.
CHCRF
$0.66
$0.000.00%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 25.14% | -10.60% | 6.18% | -7.40% | 16.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.14% | -10.60% | 6.18% | -7.40% | 16.17% |
| Cost of Revenue | 1.36% | 9.79% | 40.28% | 17.87% | 59.41% |
| Gross Profit | 77.19% | -22.63% | -13.99% | -46.66% | -27.18% |
| SG&A Expenses | 89.86% | 155.13% | -15.57% | 7.68% | 112.17% |
| Depreciation & Amortization | 1,783.33% | 2,143.75% | 2,481.82% | 941.38% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.52% | 109.29% | 29.33% | 15.88% | 60.85% |
| Operating Income | -109.13% | -13,414.29% | -136.51% | -43.66% | -314.76% |
| Income Before Tax | -72.27% | -1,484.34% | -807.80% | -51.18% | -99.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -72.27% | -1,484.34% | -807.80% | -51.18% | -99.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.27% | -1,484.34% | -807.80% | -51.18% | -99.27% |
| EBIT | -109.13% | -13,414.29% | -136.51% | -43.66% | -314.76% |
| EBITDA | -103.34% | -7,759.09% | -94.08% | -30.58% | -323.41% |
| EPS Basic | 50.18% | -116.13% | -120.61% | -51.27% | 34.06% |
| Normalized Basic EPS | 50.00% | -117.24% | -120.92% | -51.18% | 34.36% |
| EPS Diluted | 50.18% | -116.13% | -120.61% | -51.27% | 34.06% |
| Normalized Diluted EPS | 50.00% | -117.24% | -120.92% | -51.18% | 34.36% |
| Average Basic Shares Outstanding | 245.19% | 635.56% | 311.31% | -0.04% | 202.28% |
| Average Diluted Shares Outstanding | 245.19% | 635.56% | 311.31% | -0.04% | 202.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |